Another New Grant

Secondary1st is delighted to announce that, thanks to our wonderful donors and fundraisers, we have made a grant to fund a post-doctoral researcher in a new project run by Professor Seth Coffelt at the Beatson Institute for Cancer Research at the University of Glasgow. This new project follows previous research funded by Secondary1st which identified gamma…

Nolan Does It Again

First it was the zipwire, then it was a cycle ride from Land’s End to John O’Groats and now Nolan with support from his family and friends has raised a total of more than £23,000 in memory of Nic for Secondary1st. But that isn’t enough for him as he is already planning another challenge for…

Another NICE Targeted Cancer Treatment

NICE now recommends capivasertib, also known as truqap and made by Astra Zeneca, with fulvestrant for those with HR positive HER2 negative metastatic breast cancer with certain genetic mutations after endocrine or hormone therapy. Capivasertib tablets are to be taken twice a day to block the action of an abnormal protein that tells cancer cells…

A Liquid Biopsy

The NHS in England has started offering liquid biopsies to some women with breast cancer that has mutated. These circulating tumour DNA (ctDNA) blood tests will show whether women with ER-positive HER2 negative secondary breast cancer have developed the ESR1 mutation which can sometimes occur after long-term treatment with hormone therapy. ER-positive cancer cells are…

A Nice New Drug

Olaparib (Lynparza) has now been approved by NICE as a second-line treatment of HER2-negative locally advanced or metastatic breast cancer in adults with mutated BRCA1 or BRCA2 genes who have had chemotherapy. Olaparib is a PARP inhibitor; PAPR is a protein which helps cancer cells repair themselves and Olaparib stops this repair process in these…

Research Update

In 2024 thanks to donors and fundraisers Secondary1st funded the first year of a research project led by Professor Simak Ali at Imperial College London investigating how changes in the ER gene contribute to hormone therapy resistance. About 44,000 people are diagnose with ER (oestrogen receptor) positive breast cancer each year in the UK and…

An Afternoon of Music and Song

The wonderful Alina, a specialist breast cancer nurse, arranged a pre-Christmas afternoon of music and song by courtesy of the Wellington Hospital. Three brilliant stars of musical theatre sang favourite songs from popular shows with keyboard accompaniment and helped to raise more than £600 for Secondary1st.